FICO$1043.57+3.3%Cap: $24.8BP/E: 33.152w: [=|---------](Apr 29)
Setup
FICO printed Q2 FY2026 on April 28. Stock is down 47% over twelve months and trades at $1,044.81 — 13% of its 52-week range, 19.5x forward P/E against a 91%-margin Scores monopoly and a Platform business growing +49% YoY. Sell-side mean target sits at $1,598 (+53%). The filing showed acceleration in the metrics that test the thesis, not deceleration.
What the filing says
Platform ARR reached $348.8M, +49% YoY — accelerating from +33% the prior quarter. Platform DBNRR jumped 14 points sequentially to 136% (was 122% in Q1, 110% one year ago). At trajectory, Platform ARR crosses non-platform ARR ($440M, -8% YoY) by Q4 FY2026. ACV bookings $66.1M H1 vs $43.0M prior year (+54%) — forward pipeline leading reported ARR.
Scores revenue $475M (+60% YoY), B2B Scores +72%, segment operating margin 91% (up from 89%). Driver disclosed verbatim: "higher unit price and an increase in volume of mortgage originations." Bureau revenue concentration jumped to 64% (from 52% in prior year Q2) — all three credit bureaus individually exceed 10% of FICO revenues. Total revenue $691.7M (+39%), Q2 diluted EPS $11.14 vs $6.59 (+69%).
CEO William Lansing terminated his 10b5-1 trading plan March 26 — for ≈55,000 shares running through December 2026, established November 2025. Form 4 verification confirms zero personal code-S sales between plan establishment and termination. Stock was $1,183 on the termination date; ≈55,000 shares of authorization went unused.
Software segment margin compressed to 29% (vs 31% PY) — second consecutive quarter at this level, attributed to cloud infrastructure costs and mix shift toward ratable SaaS.
Cross-ticker math conserves
TRU 10-Q (filed 4/28) cites "FICO mortgage royalties" as primary cost driver, -100bps consolidated EBITDA drag. EFX 10-Q (filed 4/21): USIS margin 21.1% → 20.2% "primarily due to higher royalty costs in USIS." Combined bureau cost increase ≈ $180M YoY ≈ FICO's B2B Scores revenue increase of $175M. Math is conserved across three independent SEC filings, same calendar quarter. The royalty flywheel ($4.95 → $10 per-score, 20x since 2018) is documented from supply and demand sides simultaneously.
What the market thinks
Trailing-250d factor regression: 93.4% idiosyncratic variance, SPY β +2.97, QQQ β -1.43 — tape priced FICO as AI-loser, trading inversely to tech. Residual α = -70.7% annualized — that's the compression in price.
Options: ATM IV 58.5% (59th percentile of 52-wk range), max pain $1,040 at spot. P/C OI 0.79 (bullish at the open-interest level); today's flow P/C 1.46 with 29 unusual put strikes (bearish flow into May 15 expiry). Positioning is mixed.
Sell-side: 15 buy/strong-buy vs 5 hold, 1 sell. The most recent print was the fourth consecutive earnings beat (+13.9%).
Where the gap is
Reverse-solving market-implied scenario probabilities at $1,044 against fundamentally derived targets (≈$1,915 bull / ≈$1,359 base / ≈$1,004 muddle / ≈$644 bear) yields a Bull probability of ≈15-25% depending on scenario-midpoint assumptions. Filing-grounded reading suggests 35-45%. The gap is roughly +15-25pp on the bull case — wider than scenario-precision noise.
EV at $1,468 implies +40% over 12-18 months, Sharpe 0.76 (under the 0.5-1.0 plausibility ceiling). Notably, my EV is below sell-side mean target $1,598 — alpha here is not "see what analysts miss" but "tape hasn't priced what analysts already see."
Why the gap exists
AI-disruption narrative is sticky; the QQQ -1.43 beta says the market processed FICO as Zoom-analog. VantageScore overhang carries an uncertainty premium even though GSE submission share has held <5% nine months after FHFA authorization. Hedge fund net software exposure is at record lows (GS Prime data) — flow positioning, not fundamentals. The cross-ticker math conservation — bureaus literally naming FICO as their cost driver — is buried in TRU/EFX 10-Q footnotes that retail and most sell-side don't synthesize.
Risks (ranked)
- VantageScore GSE share breaks 15% by year-end — forces LLPA grid reconciliation, moat erodes (low probability: 9mo at <5%, but 85% is not 99%)
- Sherman §2 antitrust pricing remedy — claim survived dismissal Nov 2024, in discovery, no schedule disclosed
- Mortgage cycle reversal — rate spike kills refi volume, flywheel stalls
- Software margin compression below 27% — cloud opex drag becomes structural
- Leverage approaches 3.5x covenant — $3.64B debt, coverage 9x today, but $1.5B issued in 12mo at 6.0-6.25%; buyback flywheel breaks if credit tightens
Catalysts
| Date | Event | Predicts |
|---|---|---|
| ≈2026-07-25 | TRU Q2 cal 2026 10-Q | FICO royalty third-quarter disclosure (80%) |
| ≈2026-07-25 | EFX Q2 cal 2026 10-Q | Same pattern |
| ≈2026-08-05 | FICO Q3 FY2026 10-Q | DBNRR ≥130% (60%) |
| ≈2026-11-15 | FICO FY2026 10-K | Platform > Non-platform crossover (65%) |
| 2026-12-31 | FHFA quarterly data | VantageScore <15% GSE (85%) |
Cluster point: late July through early August 2026 — three predictions resolve in a two-week window.
What would change our mind
- Platform DBNRR drops below 120% in Q3 FY2026 — structural deceleration confirmed
- FHFA report shows VantageScore GSE submission share at 15%+ in any quarter — regulatory moat eroding
- Sherman §2 ruling or settlement forces structural pricing concession
- Mortgage origination volume drops >30% YoY for two consecutive quarters
- Bureau revenue concentration crosses 70% AND one bureau publicly threatens defection
- Stock breaks $850 on volume without identifiable news — tape priced something the filings haven't disclosed
Evidence
| Evidence | Source | Credibility | LR |
|---|---|---|---|
| Platform ARR $348.8M (+49% YoY), DBNRR 136% (vs 122% prior Q, 110% YoY) | 10-Q 2026-04-28, MD&A KPI table | 0.95 | 1.7 |
| Q2 revenue $691.7M (+39%), Scores B2B +72%, op margin 91%, bureau concentration 64% (vs 52% PY) | 10-Q 2026-04-28, segment disclosure | 0.95 | 1.4 |
| CEO Lansing terminated 10b5-1 March 26, zero personal code-S sales (Form 4 verified, Feb 26-27 filings uncached caveat) | 10-Q 2026-04-28 + EDGAR Form 4 | 0.85 | 1.3 |
| Bureau royalty math: TRU+EFX cost +$180M YoY ≈ FICO B2B Scores +$175M, three SEC filings same quarter | TRU 10-Q 2026-04-28, EFX 10-Q 2026-04-21, FICO 10-Q 2026-04-28 | 0.95 | 1.4 |
| FICO factor regression: 93.4% idio, QQQ β -1.43, α -70.7% annualized residual | iev regress (trailing 250d) | 0.95 | 1.3 |
| Software margin 29% (vs 31% PY), second consecutive quarter | 10-Q 2026-04-28, MD&A | 0.95 | 0.85 |
| Total debt $3.64B (up from $3.06B), coverage 9x, approaching 3.5x covenant | 10-Q 2026-04-28, Note 8 | 0.95 | 0.9 |
| Sell-side mean target $1,598 (+53% from spot), 15 buy/strong-buy vs 5 hold, 1 sell | yfinance consensus 2026-04-29 | 0.70 | 1.1 |
| FORTRESS-tier Q1 cal 2026 pricing power: SPGI +6.1% subscription, VRSK +5.5% organic on price, FICO Scores B2B +72% | SPGI/VRSK/FICO 10-Qs Apr 2026 | 0.95 | 1.2 |
| VantageScore <5% GSE submission share 9mo post-FHFA authorization; structural switching barriers (LLPA grids, securitization, score divergence) | FICO Q1 FY2026 transcript | 0.85 | 1.5 |
| V-Score 3.57 EMBEDDED (E=5, M=5, C=4, U=3, A=3, F=3) — regulatory standard, not SaaS | Internal V-Score framework, primary source review | 0.92 | 1.5 |
// comments (0)